Koers BioHemp International, Inc. Other OTC
Aandelen
BKIT
US09076B1052
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Blum
CEO | Chief Executive Officer | 35 | 15-05-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Blum
CEO | Chief Executive Officer | 35 | 15-05-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+48,79% | 781 mld. | |
+41,61% | 639 mld. | |
+19,43% | 330 mld. | |
+7,18% | 293 mld. | |
+17,54% | 248 mld. | |
+0,25% | 221 mld. | |
+11,55% | 217 mld. | |
+4,53% | 162 mld. | |
-3,92% | 157 mld. |